Research

SITraN is focused on translational neuroscience. The goal of our research is to harness scientific developments emerging from experimental work in the laboratory and translate these insights into effective therapies and better outcomes for patients.

Head up collar shown on mannequin

Motor neurone disease

The SITraN scientific research programmes are dedicated to developing effective disease-modifying therapies for neurodegenerative diseases of the human motor system.

Developing effective MND treatments

Man Listening to music with headphones

Dementia

Dementia affects over 830,000 people in the UK and approximately 36 million people worldwide.

Detecting and preventing dementia

patient receiving clinical care

Stroke

Our stroke research specialises in rehabilitation trials to improve outcomes for patients, biomarker studies and preclinical stroke prevention therapy development

Stroke

Parkinson's disease: nerve cells - illustration

Parkinson's disease

Each day, 80 people in the UK are newly diagnosed with Parkinson's disease, which affects over six million people globally.

Our research into Parkinson's

Child and teddy bear

Spinal muscular atrophy

Spinal muscular atrophy (SMA) is a form of motor neuron degeneration that usually starts during foetal development and is one of the most common genetic causes of infant death.

Understanding SMA

Image relating to multiple sclerosis

Multiple Sclerosis

We lead a portfolio of preclinical and clinical research to improve our understanding and treatment for multiple sclerosis.

Multiple Sclerosis